Position in TERN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
New position
Shares Held
1,000,001
first reported quarter
Ownership
0.866%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Derivatives in TERN
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$0
PutShares
500,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026WHITEBOX ADVISORS LLC holds $208,093,702 across 8 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TECH |
BIO-TECHNE Corp
|
2,100,001 | $148,365,070 | |
| 2 | APGE |
Apogee Therapeutics, Inc.
|
450,001 | $59,728,632 | |
| 3 | ESLA |
Estrella Immunopharma, Inc.
|
42,293 | $0 | |
| 4 | NUVL |
Nuvalent, Inc.
|
275,001 | $0 | |
| 5 | ASBP |
Aspire Biopharma Holdings, Inc.
|
118,750 | $0 | |
| 6 | TVGN |
Tevogen Inc.
|
86,292 | $0 | |
| 7 | VRXA |
Veraxa Biotech Holding AG
|
193,612 | $0 | |
| 8 | DRTS |
Alpha Tau Medical Ltd.
|
136,018 | $0 |
All Filings in TERN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 500,000 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | — | 1,000,001 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||